Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study

Abstract Background It is known that the risk of ischemic heart disease increases in patients with type 2 diabetes mellitus (T2DM). For female patients, the incidence of heart disease can be even greater after menopause, accompanied by dramatic changes in sex hormones. We investigated the correlatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Yahao Wang, Yixuan Li, Chuanfeng Liu, Yangang Wang, Yiming Li
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Journal of Diabetes
Subjects:
Online Access:https://doi.org/10.1111/1753-0407.70005
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850059682691940352
author Yahao Wang
Yixuan Li
Chuanfeng Liu
Yangang Wang
Yiming Li
author_facet Yahao Wang
Yixuan Li
Chuanfeng Liu
Yangang Wang
Yiming Li
author_sort Yahao Wang
collection DOAJ
description Abstract Background It is known that the risk of ischemic heart disease increases in patients with type 2 diabetes mellitus (T2DM). For female patients, the incidence of heart disease can be even greater after menopause, accompanied by dramatic changes in sex hormones. We investigated the correlations between sex hormones and markers of ischemic heart diseases in postmenopausal females with T2DM patients. Methods This cross‐sectional study collected data from 324 hospitalized postmenopausal females with T2DM. Multiple linear regression analyses were conducted to determine the correlations between sex hormones and cardiac markers including high‐sensitive cardiac troponin T (hs‐cTnT) and N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) levels. Results Multiple linear regression analyses revealed that luteinizing hormone (LH) was positively and independently associated with hs‐cTnT concentrations in postmenopausal females with T2DM (β = 0.189, p = 0.002). Postmenopausal females with T2DM and subclinical myocardial injury had higher LH levels than those without subclinical myocardial injury (29.67 vs. 25.08 mIU/mL, p < 0.001). A multivariate logistic regression analysis confirmed an independent and significant association between elevated LH and subclinical myocardial injury in postmenopausal females with T2DM (adjusted odds ratio [OR] = 1.077, 95% confidence interval [CI], 1.033–1.124; p < 0.001). As another gonadotropin, the follicle‐stimulating hormone did not show independent correlations with hs‐cTnT or NT‐proBNP (p > 0.05). Neither estrogen nor testosterone was correlated with cardiac markers. Conclusions Elevated LH levels were positively and independently associated with increased hs‐cTnT levels in postmenopausal women with T2DM. Our findings suggest that LH could serve as a potential marker for assessing the risk of subclinical myocardial injury in postmenopausal females with T2DM.
format Article
id doaj-art-40e2d1c396414f4f87949b554e08329b
institution DOAJ
issn 1753-0393
1753-0407
language English
publishDate 2024-10-01
publisher Wiley
record_format Article
series Journal of Diabetes
spelling doaj-art-40e2d1c396414f4f87949b554e08329b2025-08-20T02:50:48ZengWileyJournal of Diabetes1753-03931753-04072024-10-011610n/an/a10.1111/1753-0407.70005Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional studyYahao Wang0Yixuan Li1Chuanfeng Liu2Yangang Wang3Yiming Li4Department of Endocrinology, Huashan Hospital Fudan University Shanghai ChinaDepartment of Endocrinology The Affiliated Hospital of Qingdao University Qingdao ChinaDepartment of Endocrinology The Affiliated Hospital of Qingdao University Qingdao ChinaDepartment of Endocrinology The Affiliated Hospital of Qingdao University Qingdao ChinaDepartment of Endocrinology, Huashan Hospital Fudan University Shanghai ChinaAbstract Background It is known that the risk of ischemic heart disease increases in patients with type 2 diabetes mellitus (T2DM). For female patients, the incidence of heart disease can be even greater after menopause, accompanied by dramatic changes in sex hormones. We investigated the correlations between sex hormones and markers of ischemic heart diseases in postmenopausal females with T2DM patients. Methods This cross‐sectional study collected data from 324 hospitalized postmenopausal females with T2DM. Multiple linear regression analyses were conducted to determine the correlations between sex hormones and cardiac markers including high‐sensitive cardiac troponin T (hs‐cTnT) and N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) levels. Results Multiple linear regression analyses revealed that luteinizing hormone (LH) was positively and independently associated with hs‐cTnT concentrations in postmenopausal females with T2DM (β = 0.189, p = 0.002). Postmenopausal females with T2DM and subclinical myocardial injury had higher LH levels than those without subclinical myocardial injury (29.67 vs. 25.08 mIU/mL, p < 0.001). A multivariate logistic regression analysis confirmed an independent and significant association between elevated LH and subclinical myocardial injury in postmenopausal females with T2DM (adjusted odds ratio [OR] = 1.077, 95% confidence interval [CI], 1.033–1.124; p < 0.001). As another gonadotropin, the follicle‐stimulating hormone did not show independent correlations with hs‐cTnT or NT‐proBNP (p > 0.05). Neither estrogen nor testosterone was correlated with cardiac markers. Conclusions Elevated LH levels were positively and independently associated with increased hs‐cTnT levels in postmenopausal women with T2DM. Our findings suggest that LH could serve as a potential marker for assessing the risk of subclinical myocardial injury in postmenopausal females with T2DM.https://doi.org/10.1111/1753-0407.70005hs‐cTnTluteinizing hormonepostmenopausesubclinical myocardial necrosistype 2 diabetes mellitus
spellingShingle Yahao Wang
Yixuan Li
Chuanfeng Liu
Yangang Wang
Yiming Li
Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
Journal of Diabetes
hs‐cTnT
luteinizing hormone
postmenopause
subclinical myocardial necrosis
type 2 diabetes mellitus
title Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
title_full Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
title_fullStr Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
title_full_unstemmed Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
title_short Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
title_sort luteinizing hormone is independently associated with high sensitive cardiac troponin t elevation in postmenopausal t2dm patients a cross sectional study
topic hs‐cTnT
luteinizing hormone
postmenopause
subclinical myocardial necrosis
type 2 diabetes mellitus
url https://doi.org/10.1111/1753-0407.70005
work_keys_str_mv AT yahaowang luteinizinghormoneisindependentlyassociatedwithhighsensitivecardiactroponintelevationinpostmenopausalt2dmpatientsacrosssectionalstudy
AT yixuanli luteinizinghormoneisindependentlyassociatedwithhighsensitivecardiactroponintelevationinpostmenopausalt2dmpatientsacrosssectionalstudy
AT chuanfengliu luteinizinghormoneisindependentlyassociatedwithhighsensitivecardiactroponintelevationinpostmenopausalt2dmpatientsacrosssectionalstudy
AT yangangwang luteinizinghormoneisindependentlyassociatedwithhighsensitivecardiactroponintelevationinpostmenopausalt2dmpatientsacrosssectionalstudy
AT yimingli luteinizinghormoneisindependentlyassociatedwithhighsensitivecardiactroponintelevationinpostmenopausalt2dmpatientsacrosssectionalstudy